moclobemide and Tremor
moclobemide has been researched along with Tremor in 3 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"An international, multicenter, placebo-controlled study was undertaken to determine the safety and antidepressant efficacy of moclobemide, a new reversible inhibitor of monoamine oxidase A, and imipramine in the treatment of dysthymia (DSM-III-R)." | 9.08 | Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. ( Amrein, R; Stabl, M; Versiani, M, 1997) |
"An international, multicenter, placebo-controlled study was undertaken to determine the safety and antidepressant efficacy of moclobemide, a new reversible inhibitor of monoamine oxidase A, and imipramine in the treatment of dysthymia (DSM-III-R)." | 5.08 | Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. ( Amrein, R; Stabl, M; Versiani, M, 1997) |
" Thirty-eight patients with episodic, chronic and atypical depressive disorder (DSM-III) were equally randomized to 6 weeks' treatment with either three daily doses of 100 mg moclobemide or 50 mg clomipramine." | 5.05 | Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial. ( Holm, P; Larsen, JK; Mikkelsen, PL, 1984) |
"The current study was aimed at investigating the effect of Areca catechu nut dichloromethane fraction (7 mg/kg) on monoamines (serotonin and dopamine) modulation (5-hydroxytryptophan-induced tremors and phenylethylamine-induced stereotypes) and its interaction with tyramine (cheese effect)." | 3.80 | Effect of dichloromethane fraction of Areca catechu nut on monoamines associated behaviors and tyramine pressor sensitivity in rodents. ( Abbas, G; Ahmed, FS; Dar, A; Khan, S; Rahman, A, 2014) |
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Khan, S | 1 |
Abbas, G | 1 |
Ahmed, FS | 1 |
Rahman, A | 1 |
Dar, A | 1 |
Larsen, JK | 1 |
Holm, P | 1 |
Mikkelsen, PL | 1 |
Versiani, M | 1 |
Amrein, R | 1 |
Stabl, M | 1 |
Trials
2 trials available for moclobemide and Tremor
Article | Year |
---|---|
Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
Topics: Adult; Aged; Benzamides; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dizziness; Dou | 1984 |
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Consti | 1997 |
Other Studies
1 other study available for moclobemide and Tremor
Article | Year |
---|---|
Effect of dichloromethane fraction of Areca catechu nut on monoamines associated behaviors and tyramine pressor sensitivity in rodents.
Topics: 5-Hydroxytryptophan; Animals; Areca; Behavior, Animal; Biogenic Monoamines; Blood Pressure; Dopamine | 2014 |